BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liao CS, Lin YM, Chang HC, Chen YH, Chong LW, Chen CH, Lin YS, Yang KC, Shih CH. Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia. World J Gastroenterol 2013; 19(45): 8366-8372 [PMID: 24363529 DOI: 10.3748/wjg.v19.i45.8366]
URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8366.htm
Number Citing Articles
1
J. S. Hunt, C. Cock, E. L. Symonds. A True Positive and a False Negative? The Dilemma of Negative Colonoscopy After a Positive Fecal Occult Blood TestDigestive Diseases and Sciences 2022; 67(5): 1843 doi: 10.1007/s10620-021-06986-4
2
Chan Hyuk Park, Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn. Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factorsGastrointestinal Endoscopy 2019; 89(6): 1204 doi: 10.1016/j.gie.2019.02.023
3
Emilie C. H. Breekveldt, Esther Toes‐Zoutendijk, Hilliene J. van de Schootbrugge‐Vandermeer, Lucie de Jonge, Arthur I. Kooyker, Manon C. W. Spaander, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp‐Vogelaar. Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening programInternational Journal of Cancer 2023; 152(8): 1536 doi: 10.1002/ijc.34373
4
Meng‐Yu Chen, Hung‐Chuen Chang, Lee‐Won Chong, Yuh‐Hwa Liu, Cheuk‐Kay Sun, Kuo‐Ching Yang, Yu‐Min Lin. Relatively low risk and nonaggressive stage of colorectal cancer in individuals with negative baseline fecal immunochemical test results: A cohort studyAdvances in Digestive Medicine 2021; 8(1): 19 doi: 10.1002/aid2.13169
5
H. Ghajari, A. Sadeghi, S. Khodakarim, M. Zali, S. S. Hashemi Nazari. Designing a Predictive Model for Colorectal Neoplasia Diagnosis Based on Clinical and Laboratory Findings in Colonoscopy Candidate PatientsJournal of Gastrointestinal Cancer 2022; 53(4): 880 doi: 10.1007/s12029-021-00737-4
6
Dae Ho Kim, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Young-Hak Cho, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee. Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in KoreaGut and Liver 2018; 12(2): 183 doi: 10.5009/gnl17030
7
Po-Hsiang Ting, Xi-Hsuan Lin, Jeng-Kai Jiang, Jiing-Chyuan Luo, Ping-Hsien Chen, Yen-Po Wang, I-Fang Hsin, Chin Lin Perng, Ming-Chih Hou, Fa-Yauh Lee. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomesJournal of the Chinese Medical Association 2018; 81(9): 759 doi: 10.1016/j.jcma.2017.11.015
8
Yoon Suk Jung. Strategies for colorectal cancer screening and post-polypectomy surveillance for young adults under age 50Precision and Future Medicine 2021; 5(2): 69 doi: 10.23838/pfm.2021.00051
9
Mercedes Navarro, Gonzalo Hijos, Teresa Ramirez, Ignacio Omella, Patricia Carrera-Lasfuentes, Ángel Lanas. Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic PatientsFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00091
10
Sherry Yueh-Hsia Chiu, Shu-Ling Chuang, Sam Li-Sheng Chen, Amy Ming-Fang Yen, Jean Ching-Yuan Fann, Dun-Cheng Chang, Yi-Chia Lee, Ming-Shiang Wu, Chu-Kuang Chou, Wen-Feng Hsu, Shu-Ti Chiou, Han-Mo Chiu. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening ProgramGut 2017; 66(2): 293 doi: 10.1136/gutjnl-2015-310256
11
Ian M. Godber, Louise M. Todd, Callum G. Fraser, Linda R. MacDonald, Hakim Ben Younes. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptomsClinical Chemistry and Laboratory Medicine (CCLM) 2016; 54(4) doi: 10.1515/cclm-2015-0617
12
Josep M. Auge, Maria Pellise, José M. Escudero, Cristina Hernandez, Montserrat Andreu, Jaume Grau, Andrea Buron, María López-Cerón, Xavier Bessa, Anna Serradesanferm, Mercè Piracés, Francesc Macià, Rafael Guayta, Xavier Filella, Rafael Molina, Wladimiro Jimenez, Antoni Castells. Risk Stratification for Advanced Colorectal Neoplasia According to Fecal Hemoglobin Concentration in a Colorectal Cancer Screening ProgramGastroenterology 2014; 147(3): 628 doi: 10.1053/j.gastro.2014.06.008
13
James E. Allison, Callum G. Fraser, Stephen P. Halloran, Graeme P. Young. Colorectal Cancer Screening2015; : 65 doi: 10.1007/978-1-4939-2333-5_4
14
Hsin‐Yeh Yang, Yu‐Min Lin, Lee‐Won Chong, Hung‐Chuen Chang, Chao‐Sheng Liao, Kuo‐Ching Yang. Performance of quantitative immunochemical test for fecal hemoglobin for surveillance of colorectal neoplasia after polypectomy in clinical practiceAdvances in Digestive Medicine 2017; 4(4): 128 doi: 10.1002/aid2.12128
15
Szu-Min Peng, Han-Mo Chiu, Hsiao-Hsuan Jen, Chen-Yang Hsu, Sam Li-Sheng Chen, Sherry Yueh-Hsia Chiu, Amy Ming-Fang Yen, Jean Ching-Yuan Fann, Yi-Chia Lee, Hsiu-Hsi Chen. Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screeneesBMC Medical Informatics and Decision Making 2019; 19(1) doi: 10.1186/s12911-019-0812-1
16
Christian Balamou, Akoï Koïvogui, Christelle M Rodrigue, Aurélie Clerc, Claire Piccotti, Anne Deloraine, Catherine Exbrayat. Prediction of the severity of colorectal lesion by fecal hemoglobin concentration observed during previous test in the French screening programWorld Journal of Gastroenterology 2021; 27(31): 5272-5287 doi: 10.3748/wjg.v27.i31.5272
17
Han-Mo Chiu, Li-Chun Chang, Wen-Feng Hsu, Chu-Kuang Chou, Ming-Shiang Wu. Non-invasive screening for colorectal cancer in AsiaBest Practice & Research Clinical Gastroenterology 2015; 29(6): 953 doi: 10.1016/j.bpg.2015.09.015
18
Nam Hee Kim, Min-Jung Kwon, Hyun-young Kim, Taeheon Lee, Seok Hyeon Jeong, Dong Il Park, Kyuyong Choi, Yoon Suk Jung. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasiaDigestive and Liver Disease 2016; 48(6): 667 doi: 10.1016/j.dld.2016.03.001
19
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02670-1
20
Montse Garcia. Addressing overuse and overdiagnosis in colorectal cancer screening for average-risk individualsColorectal Cancer 2015; 4(1): 27 doi: 10.2217/crc.15.4